A prospective feasibility trial exploring novel biomarkers for neurotoxicity after isolated limb perfusion.

During ILP, NfL and tau levels increased significantly. No obvious correlations were observed between biomarker release and regional toxicity or decreased muscle strength or sensitivity, although large-scale studies are warranted.